Press release
Genetic Engineering Drug Market 2021 Size, Growth Analysis Report, Forecast to 2027
The global genetic engineering drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Genetic engineering drugs include hormones, enzymes, growth and coagulation factors, antibodies as well as vaccines and are generated by using recombinant DNA technology. Additionally, they are categorized by high and specific activity in the presence of optimal safety. The major factor driving the demand for the genetic engineering drug is the new drug launches and strategic initiatives from the key players in the market across the globe.For instance, in December 2021, GlaxoSmithKline plc announced a five-year collaboration with Lyell Immunopharma. The collaboration was aimed to develop new technologies to improve cell therapies for cancer patients and will apply Lyell's technologies to further strengthen GSK's cell therapy pipeline which includes GSK3377794. GSK3377794 uses genetically engineered autologous T cells and is currently in Phase 2. Additionally, in January 2022, Pfizer Inc. announced an exclusive four-year research collaboration with Beam Therapeutics Inc. The collaboration is focused on in vivo base editing programs for three targets for rare genetic diseases of the liver, muscle and central nervous system
To Request a Sample of our Report on Genetic Engineering Drug Market: https://www.omrglobal.com/request-sample/genetic-engineering-drug-market
Some major players in the market include Pfizer Inc., GlaxoSmithKline plc, and Eli Lilly and Co., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in February 2022, Eli Lilly and Company announced the launch of the Lilly Institute for Genetic Medicine. Additionally, the company announced an investment of approximately $700 million to establish a state-of-the-art facility at a new site in the Boston Seaport.
Market Coverage
• The market number available for - 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
Segment Covered-
• By Product
• By Application
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
Competitive Landscape- Pfizer Inc., GlaxoSmithKline plc, and Eli Lilly and Co., among others.
(Get 15% Discount on Buying this Report)
A full Report of Genetic Engineering Drug Market is Available @ https://www.omrglobal.com/industry-reports/genetic-engineering-drug-market
Global Genetic Engineering Drug Market Report by Segment
By Product
• Monoclonal Antibody
• Recombinant Human Erythropoietin
• Recombinant Human Interferon
• Recombinant Human Growth Hormone
• Recombinant Human Insulin
By Application
• Less Than 30 Years Old
• 30 Years-60 Years Old
• Above 60 Years
Global Genetic Engineering Drug Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genetic Engineering Drug Market 2021 Size, Growth Analysis Report, Forecast to 2027 here
News-ID: 2578514 • Views: …
More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…

Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…

Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…

SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Genetic
Increasing Prevalence Of Genetic Disorders Fuels Growth In Genetic Testing Servi …
The Genetic Testing Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Genetic Testing Services Market Size During the Forecast Period?
The genetic testing services market has expanded rapidly in recent years. It will grow from $19.19 billion in 2024 to $21.42…
Preimplantation Genetic Testing Market Unlocking Innovations and Future Opportun …
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
The field of reproductive medicine has witnessed groundbreaking advancements in recent years, with preimplantation genetic testing (PGT) emerging as a pivotal innovation. This technology, designed to analyze embryos for genetic abnormalities before implantation during in vitro fertilization (IVF), has revolutionized assisted reproductive techniques, offering hope to countless couples seeking healthy pregnancies.
The preimplantation genetic testing market is projected to grow from a value of US$0.68 billion in 2024 to US$1.48…
Animal Genetic Market poised for growth with advancements in genetic testing by …
𝐀𝐧𝐢𝐦𝐚𝐥 𝐆𝐞𝐧𝐞𝐭𝐢𝐜 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the Animal Genetic Market. The report includes key business insights, demand analysis, pricing analysis, and competitive landscape. The analysis in the report provides an in-depth aspect at the current status of the Animal Genetic market, with forecasts outspreading to the year 2030.
𝐒𝐞𝐜𝐮𝐫𝐞 𝐲𝐨𝐮𝐫 𝐬𝐚𝐦𝐩𝐥𝐞 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞𝐥𝐲: https://www.maximizemarketresearch.com/request-sample/31913/
𝐄𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐄𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧…
Genetic Testing Services Market Report 2024 - Genetic Testing Services Market Tr …
"The Business Research Company recently released a comprehensive report on the Global Genetic Testing Services Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The genetic testing services…
Genetic Testing Services Market - Knowledge for better health: Genetic testing s …
Newark, New Castle, USA: The "Genetic Testing Services Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Genetic Testing Services Market: https://www.growthplusreports.com/report/genetic-testing-services-market/7929
This latest report researches the industry structure,…
Breast Cancer Predictive Genetic Testing Market Breast Cancer Predictive Genetic …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Cancer Susceptibility Testing
1.1 Prologue to Cancer Susceptibility
1.2 Aspects of Cancer Susceptibility Testing
Breast Cancer Susceptibility
2.1 Conceptual of Breast Cancer Susceptibility
2.2 Trail of the Inherited Susceptible Genes
Hereditary Breast Cancer Genes
3.1 High Penetrant Genes
3.1.1 Breast Cancer Gene1 (BRCA1)
3.1.2 Breast Cancer Gene 2 (BRCA2)
…